Thursday, January 25, 2018 9:16 PM
|
The Vascular Connection to Multiple Sclerosis
The study found: An 86% reduction in migraine severity in patients with relapsing, remitting MS up to 3.5 years after angioplasty. A 77% reduction in migraine severity in patients with secondary progressive MS – improvements that lasted for 3.5 years “The results were loud and clear," said study co-author Clive Beggs, a professor of physiology at Leeds Beckett University in the U.K. A new study suggests that a highly controversial treatment for multiple sclerosis may in fact reduce headaches in patients with multiple sclerosis and other neurological conditions.
|